Community Papers

Richmond Hospital Foundation announces its 2014 board of directors

Richmond Hospital Foundation has elected its 2014 board of directors with four new board members and a new board executive.

“Our new board reflects the strength, talent and diversity of Richmond,” said Doug Johnson, Richmond Hospital Foundation’s new board chair.

“In 2014, Richmond Hospital Foundation looks forward to building on momentum to work actively with donors to provide exemplary local health care in Richmond.”

New to the board this year are: Chris Ho (a barrister and solicitor with Ho & Associates), Lily Korstanje (managing director, Magnum Projects Ltd.), Russell MacKay (investment advisor, RBC Dominion Securities Inc.) and Peter Tolensky (Partner, Lawson Lundell LLP).

Richmond Hospital Foundation 2014 Board of Directors:

•Doug Johnson, chair, (partner and senior vice-president, transaction advisory services, Ernst & Young);

•Matt Ilich, vice-chair, (associate portfolio manager, Richardson GMP Limited);

•Paul Oei, vice-chair, (president and CEO, Canadian Manu Immigration & Financial Services Inc.);

•Nelson Kwan, treasurer and chair, finance, investment and audit committee (senior vice-president and corporate controller, TELUS Corporation);

•Kyle Shury, chair, governance committee (principal, Platform Properties Ltd.);

•Tazdin Esmail (pharmaceutical and biotechnology industry executive);

•Barbara Goodwin (Nuco Properties Ltd.);

•Ralph May (lawyer and partner, Campbell Froh May & Rice LLP);

Mike Nader, director (ex officio) (chief operating officer, Vancouver Coastal Health - Richmond);

Kim Schuss (vice-president and senior property manager, Dorset Realty Group Canada Ltd.);

Michelle Woo (research projects manager, Ovarian Cancer Research Program).

We encourage an open exchange of ideas on this story's topic, but we ask you to follow our guidelines for respecting community standards. Personal attacks, inappropriate language, and off-topic comments may be removed, and comment privileges revoked, per our Terms of Use. Please see our FAQ if you have questions or concerns about using Facebook to comment.